Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 12/4/20161 min de lectura
Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), is proposing to withdraw approval of all new animal drug applications (NADAs) providing for use of carbadox in medicated swine feed. This action is based on CVM's determination that the use of carbadox under the approved conditions of use results in residues of carcinogenic concern in the edible tissues of the treated swine.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →